Company intelligence / Profile preview

Axial Venture

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Axial is a venture capital firm and life sciences platform that focuses on investing in and supporting early-stage biotechnology and healthcare companies. The firm is known for its deep technical analysis and a popular newsletter that provides insights into the business of biology and drug discovery. Axial partners with founders to build companies from the ground up, often focusing on platform technologies, novel modalities, and the intersection of software and biology. Their portfolio spans various therapeutic areas, including oncology, immunology, and synthetic biology.

Industry: Investors

Beyond the preview

Go deeper on Axial Venture.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axial Venture.

Explore the full profile